Uscom Ltd - Asset Resilience Ratio
Uscom Ltd (UCM) has an Asset Resilience Ratio of 29.76% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Uscom Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Uscom Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Uscom Ltd's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Uscom Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Uscom Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$966.66K | 29.76% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$966.66K | 29.76% |
Asset Resilience Insights
- Very High Liquidity: Uscom Ltd maintains exceptional liquid asset reserves at 29.76% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Uscom Ltd Industry Peers by Asset Resilience Ratio
Compare Uscom Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Uscom Ltd (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Uscom Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 57.37% | AU$2.95 Million ≈ $2.08 Million |
AU$5.13 Million ≈ $3.63 Million |
+45.79pp |
| 2023-06-30 | 11.58% | AU$600.00K ≈ $424.54K |
AU$5.18 Million ≈ $3.67 Million |
-63.86pp |
| 2022-06-30 | 75.45% | AU$6.03 Million ≈ $4.27 Million |
AU$7.99 Million ≈ $5.66 Million |
+74.88pp |
| 2021-06-30 | 0.57% | AU$30.43K ≈ $21.53K |
AU$5.33 Million ≈ $3.77 Million |
+0.06pp |
| 2020-06-30 | 0.51% | AU$30.40K ≈ $21.51K |
AU$5.92 Million ≈ $4.19 Million |
-29.05pp |
| 2019-06-30 | 29.56% | AU$1.22 Million ≈ $865.77K |
AU$4.14 Million ≈ $2.93 Million |
-16.82pp |
| 2018-06-30 | 46.39% | AU$2.49 Million ≈ $1.76 Million |
AU$5.38 Million ≈ $3.80 Million |
+8.38pp |
| 2017-06-30 | 38.01% | AU$1.71 Million ≈ $1.21 Million |
AU$4.49 Million ≈ $3.17 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$5.71 Million ≈ $4.04 Million |
-- |
About Uscom Ltd
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more